Specific expression of the pS2 gene in subclasses of breast cancers in comparison with expression of the estrogen and progesterone receptors and the oncogene ERBB2.
about
A role for methyl-CpG binding domain protein 2 in the modulation of the estrogen response of pS2/TFF1 genehSP, the domain-duplicated homolog of pS2 protein, is co-expressed with pS2 in stomach but not in breast carcinomaHomodimerization and hetero-oligomerization of the single-domain trefoil protein pNR-2/pS2 through cysteine 58Characterization and distribution of alpha 2-adrenergic receptors in the human intestinal mucosaLasp-1, a novel type of actin-binding protein accumulating in cell membrane extensionsA Tat-induced auto-up-regulatory loop for superactivation of the human immunodeficiency virus type 1 promoterSolution structure of a trefoil-motif-containing cell growth factor, porcine spasmolytic proteinExpression of the pS2 gene in human gastric cancer cells derived from poorly differentiated adenocarcinomaEffect of omeprazole-induced achlorhydria on trefoil peptide expression in the rat stomachHigh-throughput cell-based screening reveals a role for ZNF131 as a repressor of ERalpha signaling.The 5' flanking region of the pS2 gene contains a complex enhancer region responsive to oestrogens, epidermal growth factor, a tumour promoter (TPA), the c-Ha-ras oncoprotein and the c-jun protein.Differential expression of oestrogen receptor and oestrogen inducible genes in gastric mucosa and cancer.Trefoil peptidesTrefoil peptides and surgical disease.Serum TFF1 and TFF3 but not TFF2 are higher in women with breast cancer than in women without breast cancer.The gene associated with trichorhinophalangeal syndrome in humans is overexpressed in breast cancerDietary lipids and calorie restriction affect mammary tumor incidence and gene expression in mouse mammary tumor virus/v-Ha-ras transgenic miceMCF-7 breast cancer cells transfected with protein kinase C-alpha exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotypeReciprocal modulations between p53 and Tat of human immunodeficiency virus type 1Oestrogen and colonic epithelial cell growthDeficiency in trefoil factor 1 (TFF1) increases tumorigenicity of human breast cancer cells and mammary tumor development in TFF1-knockout mice.Steroid hormone agonists and antagonists in the treatment of cancer.Characterisation of oestrogen receptor, progesterone receptor, trefoil factor 1, and epidermal growth factor and its receptor in pancreatic cystic neoplasms and pancreatic ductal adenocarcinoma.The rat gene homologous to the human gene 9-27 is involved in the development of the mammary gland.Proteomic dissection of dome formation in a mammary cell line: role of tropomyosin-5b and maspin.pS2 is an independent factor of good prognosis in primary breast cancer.Immunohistochemical localisation of pS2 protein in ductal carcinoma in situ and benign lesions of the breast.PS2 in breast cancer--alternative or complementary tool to steroid receptor status? Evaluation of 446 cases.pS2 and response to adjuvant hormone therapy in primary breast cancer.Immunoradiometric detection of pS2 and total cathepsin D in primary breast cancer biopsies: their correlation with steroid receptorsExpression of the oestrogen regulated pNR-2 mRNA in human breast cancer: relation to oestrogen receptor mRNA levels and response to tamoxifen therapy.Randomised trial of chemotherapy versus endocrine therapy in patients presenting with locally advanced breast cancer (a pilot study).c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes.c-erbB-2 oncoprotein expression in primary and advanced breast cancerpNR-2/pS2 immunohistochemical staining in breast cancer: correlation with prognostic factors and endocrine response.Expression of the pNR-2/pS2 protein in diverse human epithelial tumours.New insights on the role of hormonal therapy in ovarian cancerRelationship of PS2 with response to tamoxifen therapy in patients with recurrent breast cancer.Characterisation of a messenger RNA selectively expressed in human breast cancerThe mouse one P-domain (pS2) and two P-domain (mSP) genes exhibit distinct patterns of expression.
P2860
Q21142628-2C7FD049-B078-4432-A45A-13ED73F245AEQ24300126-2FFAD612-D62B-4DD2-A6C1-6B4A1E203E2FQ24530534-908BF43D-82F0-4C90-872D-752EA88F9C12Q24598150-9776768C-6650-4C66-897D-3DCA79406B9AQ24654369-2B545759-168D-45A1-ABCF-3A12F2DA03EBQ24684723-60C024B2-4DB6-41B8-B90A-B0B95D938014Q27731246-D659C5AD-26C5-4347-9EB6-EF09AF013A39Q28278453-3D89609B-7682-42C9-942B-1DA16BB99CE7Q28576693-21A6D8EE-7D8D-4C68-96A9-690A16B48B21Q33375216-42F6B816-8E33-4599-ADD2-72F41253C7B9Q33561391-C999C505-AD62-4B0C-AF54-DB0F7534DFC9Q33618002-EAD7739E-1364-4697-9FDE-5D87B72CFECEQ33633535-6EF313B1-968F-41C9-9D11-481958C042A5Q33670774-7A9B3A2C-C4C6-4C0A-8DDD-D1C9F6653B04Q33885064-B8C96FF3-D550-4951-9C82-6F3AA25CCFCFQ33911408-E8783457-2E34-43B9-BEF1-17E6F7ABBF2DQ34132434-C0281532-2236-42D4-9392-A6DCDBC8C1C7Q34212221-77B4FE62-A3C9-4D69-B50E-1CFF44064AB0Q34226294-1B6360BB-B6D3-408B-8C65-12815A954DD5Q34409066-3F7C9A69-049A-482A-BEE8-1F431FBD02C0Q35120439-124B029F-E2A0-4B9D-9F86-6716A5BC04D7Q35309303-995913B3-04FE-4DC0-B20B-99D31F5AD411Q35595131-6E03B86E-9D50-4FA9-BFBD-84A4ABC390D0Q35790794-AC327312-B04A-417A-A289-45186D37EAF0Q35887950-C8FEC871-20E8-4794-962E-FD2DE7AD4C96Q35976164-0B2D0519-D802-43E0-94DA-B7A45EC11232Q35976404-0118FE13-F1CF-49E0-9888-EEE9B6D2266AQ35977131-6BB13004-C7EC-461F-9364-E35D63A17735Q35977596-78B06E38-802A-4462-84F6-DFC2BE1ED3CCQ35978394-35627DF7-FEC9-43BF-A227-8D37775C09A2Q35981528-CF584D3B-68AD-409A-939A-CFCC45D53ACAQ35983045-CC4410DE-89C6-4E7A-B88A-62F2C766537CQ35983237-04C254ED-B8F6-4749-BDC0-140D7A569207Q35983286-9184039B-A998-433F-BF29-96ECBF28BD81Q35984246-F220456A-AD6D-405C-AE14-0700D04A2EB4Q35993870-FFC57B4B-B4E3-49BE-8C86-901E0E229AE7Q36001247-75FD2557-15B3-4678-96CB-823A8B58E4EEQ36080684-926350F0-C278-414A-9614-CFDE3906516DQ36139514-C60153F1-5202-419D-BC1B-C27DCDFA06A4Q36232620-2DD6CA3B-180E-4814-8DE4-B566A5ECD856
P2860
Specific expression of the pS2 gene in subclasses of breast cancers in comparison with expression of the estrogen and progesterone receptors and the oncogene ERBB2.
description
1987 nî lūn-bûn
@nan
1987 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Specific expression of the pS2 ...... eptors and the oncogene ERBB2.
@ast
Specific expression of the pS2 ...... eptors and the oncogene ERBB2.
@en
Specific expression of the pS2 ...... eptors and the oncogene ERBB2.
@nl
type
label
Specific expression of the pS2 ...... eptors and the oncogene ERBB2.
@ast
Specific expression of the pS2 ...... eptors and the oncogene ERBB2.
@en
Specific expression of the pS2 ...... eptors and the oncogene ERBB2.
@nl
prefLabel
Specific expression of the pS2 ...... eptors and the oncogene ERBB2.
@ast
Specific expression of the pS2 ...... eptors and the oncogene ERBB2.
@en
Specific expression of the pS2 ...... eptors and the oncogene ERBB2.
@nl
P2093
P2860
P356
P1476
Specific expression of the pS2 ...... eptors and the oncogene ERBB2.
@en
P2093
Bellocq JP
Calderoli H
Rasmussen UB
P2860
P304
P356
10.1073/PNAS.84.24.9243
P407
P577
1987-12-01T00:00:00Z